Difference between revisions of "DZI20-200-Case-4"

From MGH Learn Pathology
(Edited automatically from page DZI20-200.)
(Automatic edit to upgrade to new templates)
Line 1: Line 1:
{{dziCase
+
{{ServiceRequestCase
|qc=yes
+
|identifier=DZI20-200-Case-4
|qcuser=Aja51
+
|intent=order
|qctime=Jan 15, 2021 14:33:25
+
|category=409073007
|order_date=January 05, 2021 03:57:58 PM
+
|priority=routine
|user=Mjf79
+
|orderDetail=case
|dziorder=DZI20-200
+
|locationCode=learn
|case_id=4
+
|basedOn=DZI20-200
|publish_timestamp=2021/01/15 14:00
+
|code=study
|clinical_hx="Cholangiocarcinoma. (Slides 1-3): ""Right, left and common hepatic duct"" - oriented Y-shaped tubular portion of ST. Left hepatic duct shaved --> FX1 (1st slide), Right hepatic duct shaved --> FX1A (2nd slide), common hepatic duct shaved --> FX1B (3rd slide). Specimen opened to reveal a thickened fibrotic wall (up to 0.6 cm).
+
|requisition=Frozen Conference
4th slide: ""jejunal margin of hepatojejunostomy"" - tubular ST, EF-->FX2 (4th slide).
+
|supportingInfo="FX1(left hepatic duct margin): Positive for malignancy.
5th slide: ""new proximal left duct margin"" - tubular ST, EF-->FX3 (5th slide)"
 
|case_diagnosis="FX1(left hepatic duct margin): Positive for malignancy.
 
 
FX1A(Right hepatic duct margin): high-grade dysplasia with concern for cancerization of duct.  
 
FX1A(Right hepatic duct margin): high-grade dysplasia with concern for cancerization of duct.  
 
FX#1B(common hepatic duct margin): Adenocarcinoma.
 
FX#1B(common hepatic duct margin): Adenocarcinoma.
Line 22: Line 20:
 
FX2(jejunal margin of hepaticojejunostomy): Small intestine with marked reactive atypia and acute and chronic inflammation. TINEM.
 
FX2(jejunal margin of hepaticojejunostomy): Small intestine with marked reactive atypia and acute and chronic inflammation. TINEM.
 
FX3(New proximal left duct margin): invasvie adenocarcinoma, best seen on FX slides."
 
FX3(New proximal left duct margin): invasvie adenocarcinoma, best seen on FX slides."
 +
|reasonCode="Cholangiocarcinoma. (Slides 1-3): ""Right, left and common hepatic duct"" - oriented Y-shaped tubular portion of ST. Left hepatic duct shaved --> FX1 (1st slide), Right hepatic duct shaved --> FX1A (2nd slide), common hepatic duct shaved --> FX1B (3rd slide). Specimen opened to reveal a thickened fibrotic wall (up to 0.6 cm).
 +
4th slide: ""jejunal margin of hepatojejunostomy"" - tubular ST, EF-->FX2 (4th slide).
 +
5th slide: ""new proximal left duct margin"" - tubular ST, EF-->FX3 (5th slide)"
 +
|subject=public
 +
|performer=Vd019
 +
|authoredOn=January 05, 2021 03:57:58 PM
 +
|requester=Mjf79
 +
|sequence=4
 +
}}
 +
{{Media
 +
|basedOn=DZI20-200-Case-4
 +
|type=image
 +
|view=show
 +
|partOf=DZI20-200
 +
|frames=1
 +
|identifier=DZI20-200-Case-4_1
 +
|modality=None
 
}}
 
}}
{{wsiSlide}}
+
{{Media
{{dziSlide
+
|basedOn=DZI20-200-Case-4
|order_date=January 05, 2021 03:57:58 PM
+
|type=image
|user=Mjf79
+
|view=show
|source_filename=Z0FBQUFBQmY5SXlXb2pmd2FoTWZqdnlkT2ZaUUtaY2VpQnlSS3dvT1NxX3YtamZjeVRJWWNlT0tMR0NPR2tLMEd1UXVZMS1SZTlsMWtjTzg3cm81N2FMM2M3YzhORTdFYnc9PQ
+
|partOf=DZI20-200
|slide_stain=H&E
+
|frames=2
|slide_anatomy=Show
+
|reasonCode=H&E
 +
|identifier=DZI20-200-Case-4_2
 +
|createdDateTime=January 05, 2021 03:57:58 PM
 +
|operator=Mjf79
 +
|subject=Z0FBQUFBQmY5SXlXb2pmd2FoTWZqdnlkT2ZaUUtaY2VpQnlSS3dvT1NxX3YtamZjeVRJWWNlT0tMR0NPR2tLMEd1UXVZMS1SZTlsMWtjTzg3cm81N2FMM2M3YzhORTdFYnc9PQ
 +
|modality=None
 
}}
 
}}
{{dziSlide
+
{{Media
|order_date=January 05, 2021 03:57:58 PM
+
|basedOn=DZI20-200-Case-4
|user=Mjf79
+
|type=image
|source_filename=Z0FBQUFBQmY5SXlhaFNNQlc1ekpuTURMQjNCVzlDRVNjbnlPczJzVWE0dkN1Yk0yRWFVa1VvT0tHa3VuSG8wdEN5M0hlblpFU2pLQ2JvZ2VPMU5BWHptd0lHZE1BZXE4a0E9PQ
+
|view=show
|slide_stain=H&E
+
|partOf=DZI20-200
|slide_anatomy=Show
+
|frames=3
 +
|reasonCode=H&E
 +
|identifier=DZI20-200-Case-4_3
 +
|createdDateTime=January 05, 2021 03:57:58 PM
 +
|operator=Mjf79
 +
|subject=Z0FBQUFBQmY5SXlhaFNNQlc1ekpuTURMQjNCVzlDRVNjbnlPczJzVWE0dkN1Yk0yRWFVa1VvT0tHa3VuSG8wdEN5M0hlblpFU2pLQ2JvZ2VPMU5BWHptd0lHZE1BZXE4a0E9PQ
 +
|modality=None
 
}}
 
}}
{{dziSlide
+
{{Media
|order_date=January 05, 2021 03:57:58 PM
+
|basedOn=DZI20-200-Case-4
|user=Mjf79
+
|type=image
|source_filename=Z0FBQUFBQmY5SXlkMXFsdTJ0N2FDbjNEd3lncmdiTF9ENnMxNnQzVFNYNTg0X1B6V2w0RXBMYVJDTk5Sd2o5UUNsdlZQM0R5WGc2RGQwZUtkeEtaR0MzLXptNnBLSmp6LVE9PQ
+
|view=show
|slide_stain=H&E
+
|partOf=DZI20-200
|slide_anatomy=Show
+
|frames=4
 +
|reasonCode=H&E
 +
|identifier=DZI20-200-Case-4_4
 +
|createdDateTime=January 05, 2021 03:57:58 PM
 +
|operator=Mjf79
 +
|subject=Z0FBQUFBQmY5SXlkMXFsdTJ0N2FDbjNEd3lncmdiTF9ENnMxNnQzVFNYNTg0X1B6V2w0RXBMYVJDTk5Sd2o5UUNsdlZQM0R5WGc2RGQwZUtkeEtaR0MzLXptNnBLSmp6LVE9PQ
 +
|modality=None
 
}}
 
}}
{{dziSlide
+
{{Media
|order_date=January 05, 2021 03:57:58 PM
+
|basedOn=DZI20-200-Case-4
|user=Mjf79
+
|type=image
|source_filename=Z0FBQUFBQmY5SXlnSjFMVE5MTDViemxoMnduaTNkTXRZVVJmaWM3dHlzUEpoMzJERjdpMDZ1Y1JFZWtJRkFrdXI2SkJmb2FTV25weU1oSzNRTFVKLU0yVGxYaEdGMGU4ckE9PQ
+
|view=show
|slide_stain=H&E
+
|partOf=DZI20-200
|slide_anatomy=Show
+
|frames=5
 +
|reasonCode=H&E
 +
|identifier=DZI20-200-Case-4_5
 +
|createdDateTime=January 05, 2021 03:57:58 PM
 +
|operator=Mjf79
 +
|subject=Z0FBQUFBQmY5SXlnSjFMVE5MTDViemxoMnduaTNkTXRZVVJmaWM3dHlzUEpoMzJERjdpMDZ1Y1JFZWtJRkFrdXI2SkJmb2FTV25weU1oSzNRTFVKLU0yVGxYaEdGMGU4ckE9PQ
 +
|modality=None
 
}}
 
}}
{{dziSlide
+
{{Media
|order_date=January 05, 2021 03:57:58 PM
+
|basedOn=DZI20-200-Case-4
|user=Mjf79
+
|type=image
|source_filename=Z0FBQUFBQmY5SXlrWEpRWGJ2R1BqMnYzUm9RX2JCRjhtenlqQktidDdQNnptUlZYTkFock4xYjgzaGNyQUJ5ZTYxcGRRVkV2WnZTT3diODFoWlRrYml6a0VRVXJZMHBseEE9PQ
+
|view=show
|slide_stain=H&E
+
|partOf=DZI20-200
|slide_anatomy=Show
+
|frames=6
 +
|reasonCode=H&E
 +
|identifier=DZI20-200-Case-4_6
 +
|createdDateTime=January 05, 2021 03:57:58 PM
 +
|operator=Mjf79
 +
|subject=Z0FBQUFBQmY5SXlrWEpRWGJ2R1BqMnYzUm9RX2JCRjhtenlqQktidDdQNnptUlZYTkFock4xYjgzaGNyQUJ5ZTYxcGRRVkV2WnZTT3diODFoWlRrYml6a0VRVXJZMHBseEE9PQ
 +
|modality=None
 
}}
 
}}

Revision as of 13:49, March 9, 2022

DZI20-200-Case-4
"Cholangiocarcinoma. (Slides 1-3): ""Right, left and common hepatic duct"" - oriented Y-shaped tubular portion of ST. Left hepatic duct shaved --> FX1 (1st slide), Right hepatic duct shaved --> FX1A (2nd slide), common hepatic duct shaved --> FX1B (3rd slide). Specimen opened to reveal a thickened fibrotic wall (up to 0.6 cm).

4th slide: ""jejunal margin of hepatojejunostomy"" - tubular ST, EF-->FX2 (4th slide).

5th slide: ""new proximal left duct margin"" - tubular ST, EF-->FX3 (5th slide)"
"FX1(left hepatic duct margin): Positive for malignancy.

FX1A(Right hepatic duct margin): high-grade dysplasia with concern for cancerization of duct. FX#1B(common hepatic duct margin): Adenocarcinoma. FX#2(jejunal margin of hepaticojejunostomy): c/w reactive atypia FX#3(new proximal duct margin): Positive for adenocarcinoma" "Permanent: FX1 (left and common hepatic duct margin): Invasive adenocarcinoma FX1A(Right hepatic duct margin): High-grade dysplasia FX1B(common hepatic duct margin): invasive adenocarcinom FX2(jejunal margin of hepaticojejunostomy): Small intestine with marked reactive atypia and acute and chronic inflammation. TINEM.

FX3(New proximal left duct margin): invasvie adenocarcinoma, best seen on FX slides."
December 31, 1969 7:00:00 PM